De-Risking The Unknown: Optimizing Statistical Design For Clinical Strategy

In this webinar Dr. Yannis Jemiai, Cytel’s Chief Scientific Officer, will not only answer the below questions, but share a solution for achieving clinical trial success.

• What if Governance Board meetings began with hundreds of potential clinical trial designs presented to decision-makers in an easy to visualize way?
• What if based on Governance Board questions and concerns, designs could be updated and adjusted in real time?
• What if the process revealed new desirables and showed executives how a clinical trial could be de-risked?

Join Dr. Jemiai, who will discuss Solara, a collaborative decision-support platform that has the ability to run tens of millions of simulations within minutes and communicate the benefits of various designs using graphics and other non-technical communication methods.

With Solara you can quickly illuminate tradeoffs in speed, savings and success of a clinical trial, showing Governance Boards how to quickly choose a trial beneficial for their needs. As questions arise designs can be refined in real time, saving  hundreds of hours in trial design time, and providing more rigorously justified design options from which a Governance Board can choose.